Current evidence suggests that there is an association between bisphosphonate therapy and atypical femoral fractures, but the extent of this risk remains unclear
Bisphosphonates (BPs) represent the most widely used therapy for osteoporosis. Recently, a relations...
Objective: In the past years, several cases of unusual fractures have been reported among bisphospho...
Atypical fractures related to the prolonged use of bisphosphonates are caused by low energy mechanis...
BACKGROUND: Atypical femur fracture is a rare complication of bisphosphonate treatment, which is wid...
ABSTRACT The causal relationship between chronic use of bisphosphonates and occurrences of atypical ...
Atypical femoral fractures are often associated with prolonged bisphosphonate use. The American Soci...
Increasing numbers of atypical subtrochanteric fractures have been reported among long-term bisphosp...
BackgroundBisphosphonates are effective in reducing hip and osteoporotic fractures. However, concern...
Bisphosphonates (BP) are a commonly prescribed class of drugs for the prevention of osteoporosis-rel...
Background: A number of recent case reports and series have identified a subgroup of atypical fractu...
The efficacy of using bisphosphonate therapy to treat osteoporotic patients is becoming more widely ...
Abstract Background Atypical f...
Atypical fractures of the femur below the lesser trochanter have been reported in patients treated w...
Background and purpose - Use of bisphosphonates in women is associated with higher risk of atypical ...
AbstractThe causal relationship between chronic use of bisphosphonates and occurrences of atypical f...
Bisphosphonates (BPs) represent the most widely used therapy for osteoporosis. Recently, a relations...
Objective: In the past years, several cases of unusual fractures have been reported among bisphospho...
Atypical fractures related to the prolonged use of bisphosphonates are caused by low energy mechanis...
BACKGROUND: Atypical femur fracture is a rare complication of bisphosphonate treatment, which is wid...
ABSTRACT The causal relationship between chronic use of bisphosphonates and occurrences of atypical ...
Atypical femoral fractures are often associated with prolonged bisphosphonate use. The American Soci...
Increasing numbers of atypical subtrochanteric fractures have been reported among long-term bisphosp...
BackgroundBisphosphonates are effective in reducing hip and osteoporotic fractures. However, concern...
Bisphosphonates (BP) are a commonly prescribed class of drugs for the prevention of osteoporosis-rel...
Background: A number of recent case reports and series have identified a subgroup of atypical fractu...
The efficacy of using bisphosphonate therapy to treat osteoporotic patients is becoming more widely ...
Abstract Background Atypical f...
Atypical fractures of the femur below the lesser trochanter have been reported in patients treated w...
Background and purpose - Use of bisphosphonates in women is associated with higher risk of atypical ...
AbstractThe causal relationship between chronic use of bisphosphonates and occurrences of atypical f...
Bisphosphonates (BPs) represent the most widely used therapy for osteoporosis. Recently, a relations...
Objective: In the past years, several cases of unusual fractures have been reported among bisphospho...
Atypical fractures related to the prolonged use of bisphosphonates are caused by low energy mechanis...
DOI
Add to ORKG